Skip to content

An evaluation study of change in auto-nervous system by consumption of the food which contain the aroma component of black tea.

An evaluation study of change in auto-nervous system by consumption of the food which contain the aroma component of black tea. - An evaluation study of change in auto-nervous system by consumption of the food which contain the aroma component of black tea.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038649
Enrollment
30
Registered
2020-11-23
Start date
2019-11-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake one tablet of test food - Measurement of autonomic nervous system - Intake one tablet of test food - Measurement of central nervous system 1 - Intake one tablet of test food - Measurement of ce

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Females aged 20 to 39 years old when consent obtain. (2) Females who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: 1) Females who dislike the fragrance of black tea 2) Females who have smoking habit. 3) Females who are cold-sensitive constitution. 4) Females who are receiving medication due to treatment of some disease within current one month before the test. 5) Females who are receiving treatment for pollen allergy within current one month before the test. 6) Females with stuffy nose such as allergic rhinitis or females who can't identify the fragrance. 7) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 8) Females with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 9) Females who are pregnant or are lactating. 10) Females who have symptom of dermatologic disease such as atopic dermatitis. 11) Females who have undergone surgery on investigation objective portion within the past 6 months. 12) Females who feel pain or discomfort when they bend their knee. 13) Females who are participating the other clinical tests of medicines or foods. Females who participated other clinical tests of medicines or foods within a month prior to the current study. 14) Others who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
*Evaluation of autonomic nervous system (pupil versus light reflection, skin temperature) * Evaluation of central nervous system (stabilometry, brain stress, NIRS)

Secondary

MeasureTime frame
*Multiple mood scale (short version, 40 question) *VAS questionnaire about fragrance and mood * Incidence of adverse events and side effects

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Planning & Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026